Old Web
English
Sign In
Acemap
>
authorDetail
>
Elke Schueler
Elke Schueler
Medicine
Internal medicine
Cardiology
Diabetes mellitus
Anticoagulant
4
Papers
64
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure: EMPEROR-Reduced.
2021
Journal of the American College of Cardiology
João Pedro Ferreira
Faiez Zannad
Stuart J. Pocock
Stefan D. Anker
Javed Butler
Gerasimos Filippatos
Martina Brueckmann
Waheed Jamal
Dominik Steubl
Elke Schueler
Milton Packer
Show All
Source
Cite
Save
Citations (16)
319-OR: Effects of Empagliflozin on Markers of Liver Steatosis and Fibrosis and Their Relation to Cardiorenal Outcomes in the EMPA-REG OUTCOME Trial
2021
Diabetes
Sabine Kahl
Anne Pernille Ofstad
Bernard Zinman
Christoph Wanner
Elke Schueler
Silvio E. Inzucchi
Michael Roden
Show All
Source
Cite
Save
Citations (0)
Net clinical benefit of dabigatran vs. warfarin in venous thromboembolism: analyses from RE-COVER®, RE-COVER™ II, and RE-MEDY™
2017
Journal of Thrombosis and Thrombolysis
Martin Feuring
Sam Schulman
Henry Eriksson
Ajay J. Kakkar
Sebastian Schellong
Stefan Hantel
Elke Schueler
Jörg Kreuzer
Samuel Z. Goldhaber
Show All
Source
Cite
Save
Citations (6)
Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER®, RE-COVER™ II, and RE-MEDY™
2016
Vascular Medicine
Samuel Z. Goldhaber
Henry Eriksson
Ajay K. Kakkar
Sebastian Schellong
Martin Feuring
Mandy Fraessdorf
Joerg Kreuzer
Elke Schueler
Sam Schulman
Show All
Source
Cite
Save
Citations (42)
1